195 related articles for article (PubMed ID: 12821453)
1. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.
Bartizal C; Odds FC
Antimicrob Agents Chemother; 2003 Jul; 47(7):2100-7. PubMed ID: 12821453
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
Espinel-Ingroff A
J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
[TBL] [Abstract][Full Text] [Related]
3. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
Odds FC; Motyl M; Andrade R; Bille J; Cantón E; Cuenca-Estrella M; Davidson A; Durussel C; Ellis D; Foraker E; Fothergill AW; Ghannoum MA; Giacobbe RA; Gobernado M; Handke R; Laverdière M; Lee-Yang W; Merz WG; Ostrosky-Zeichner L; Pemán J; Perea S; Perfect JR; Pfaller MA; Proia L; Rex JH; Rinaldi MG; Rodriguez-Tudela JL; Schell WA; Shields C; Sutton DA; Verweij PE; Warnock DW
J Clin Microbiol; 2004 Aug; 42(8):3475-82. PubMed ID: 15297486
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.
Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
J Clin Microbiol; 2001 Dec; 39(12):4387-9. PubMed ID: 11724849
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
[TBL] [Abstract][Full Text] [Related]
6. New methods to assess susceptibilities of Aspergillus isolates to caspofungin.
Imhof A; Balajee SA; Marr KA
J Clin Microbiol; 2003 Dec; 41(12):5683-8. PubMed ID: 14662961
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.
Pfaller MA; Diekema DJ; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2003 Mar; 47(3):1068-71. PubMed ID: 12604543
[TBL] [Abstract][Full Text] [Related]
8. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
Peter J; Armstrong D; Lyman CA; Walsh TJ
J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
[TBL] [Abstract][Full Text] [Related]
9. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro.
Bowman JC; Hicks PS; Kurtz MB; Rosen H; Schmatz DM; Liberator PA; Douglas CM
Antimicrob Agents Chemother; 2002 Sep; 46(9):3001-12. PubMed ID: 12183260
[TBL] [Abstract][Full Text] [Related]
10. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
Espinel-Ingroff A
J Clin Microbiol; 1998 Oct; 36(10):2950-6. PubMed ID: 9738049
[TBL] [Abstract][Full Text] [Related]
11. Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3.
Varga I; Sóczó G; Kardos G; Majoros L
J Antimicrob Chemother; 2008 Jul; 62(1):149-52. PubMed ID: 18390882
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
Cota J; Carden M; Graybill JR; Najvar LK; Burgess DS; Wiederhold NP
Antimicrob Agents Chemother; 2006 Nov; 50(11):3926-8. PubMed ID: 16940061
[TBL] [Abstract][Full Text] [Related]
13. Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Antimicrob Agents Chemother; 2000 Dec; 44(12):3302-5. PubMed ID: 11083631
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.
Chryssanthou E; Cuenca-Estrella M
J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895
[TBL] [Abstract][Full Text] [Related]
15. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
16. Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2004 Jul; 42(7):3117-9. PubMed ID: 15243069
[TBL] [Abstract][Full Text] [Related]
17. Detection of caspofungin resistance in Candida spp. by Etest.
Desnos-Ollivier M; Dromer F; Dannaoui E
J Clin Microbiol; 2008 Jul; 46(7):2389-92. PubMed ID: 18448691
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture.
Kahn JN; Hsu MJ; Racine F; Giacobbe R; Motyl M
Antimicrob Agents Chemother; 2006 Jun; 50(6):2214-6. PubMed ID: 16723587
[TBL] [Abstract][Full Text] [Related]
19. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of minimum inhibitory and minimum effective concentration values for the detection of in vitro susceptibilities of Aspergillus species against caspofungin].
Ozkütük A; Metin DY; Ergon C; Yücesoy M; Hilmioğlu PS
Mikrobiyol Bul; 2007 Apr; 41(2):285-90. PubMed ID: 17682716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
